iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338–2348. doi:10.1016/S0140-6736(17)31491-5
   PubMed Web of Science ®Google Scholar
• Isaacs JD, Ferraccioli G. The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):4–7. doi:10.1136/ard.2010.135376
   PubMed Web of Science ®Google Scholar
• Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117(2):244–279. doi:10.1016/j.pharmthera.2007.10.001
   PubMed Web of Science ®Google Scholar
• Ramiro S, Sepriano A, Chatzidionysiou K, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2017;76(6):1101–1136. doi:10.1136/annrheumdis-2016-210708
   PubMed Web of Science ®Google Scholar
• Xie X, Li F, Li S, et al. Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis. Clin Rheumatol. 2018;37(1):13–23.
   PubMed Web of Science ®Google Scholar
• Moots RJ, Xavier RM, Mok CC, et al. The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with Adalimumab, etanercept, or infliximab: results from a multinational, real-world clinical practice, non-interventional study. PLoS One. 2017;12(4):e0175207. doi:10.1371/journal.pone.0175207
   PubMed Web of Science ®Google Scholar
• Gao F, Liu X, Shen Z, et al. Andrographolide sulfonate attenuates acute lung injury by reducing expression of myeloperoxidase and neutrophil-derived proteases in mice. Front Physiol. 2018;9:939. doi:10.3389/fphys.2018.00939
   PubMed Web of Science ®Google Scholar
• Li X, Qiao H, Qin F, et al. Comparative analysis of iTRAQ-based proteome profiles of Schistosoma japonicum female worms coming from single-sex infections and bisexual infections. J Proteomics. 2020;213:103597. doi:10.1016/j.jprot.2019.103597
   PubMed Web of Science ®Google Scholar
• Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics. 2012;11(11):1475–1488. doi:10.1074/mcp.O112.020131
   PubMed Web of Science ®Google Scholar
• Li LH, Huang QM, Barbero M, et al. Quantitative proteomics analysis to identify biomarkers of chronic myofascial pain and therapeutic targets of dry needling in a rat model of myofascial trigger points. J Pain Res. 2019;12:283–298. doi:10.2147/JPR.S185916
   PubMed Web of Science ®Google Scholar
• Chen J, Tang MS, Xu LC, et al. Proteomic analysis of biomarkers predicting the response to triple therapy in patients with rheumatoid arthritis. Biomed Pharmacother. 2019;116:109026. doi:10.1016/j.biopha.2019.109026
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41(10):1845–1850. doi:10.1002/1529-0131(199810)41:10<1845:AID-ART17>3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359–362. doi:10.1038/nmeth.1322
   PubMed Web of Science ®Google Scholar
• Ortea I, Roschitzki B, Ovalles JG, et al. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis. J Proteomics. 2012;77:372–382. doi:10.1016/j.jprot.2012.09.011
   PubMed Web of Science ®Google Scholar
• Shilov IV, Seymour SL, Patel AA, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007;(9):1638–1655. doi:10.1074/mcp.T600050-MCP200
   PubMed Web of Science ®Google Scholar
• Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4(3):207–214. doi:10.1038/nmeth1019
   PubMed Web of Science ®Google Scholar
• Mian A, Ibrahim F, Scott DL. A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol. 2019;3:42. doi:10.1186/s41927-019-0090-7
   PubMedGoogle Scholar
• Syversen SW, Goll GL, Jørgensen KK, et al. Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, Phase IV study (the NOR-DRUM study). Trials. 2020;21(1):13. doi:10.1186/s13063-019-3734-4
   PubMed Web of Science ®Google Scholar
• Nguyen MVC, Baillet A, Romand X, et al. Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis. Joint Bone Spine. 2019;86(2):195–201. doi:10.1016/j.jbspin.2018.05.006
   PubMed Web of Science ®Google Scholar
• van Beers JJ, Raijmakers R, Alexander LE, et al. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res Ther. 2010;12(6):R219. doi:10.1186/ar3205
   PubMed Web of Science ®Google Scholar
• Blaschke S, Rinke K, Maring M, et al. Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):45. doi:10.1186/s13075-015-0553-1
   PubMedGoogle Scholar
• Tan W, Wang F, Guo D, et al. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients. Int J Rheum Dis. 2016;19(5):482–489. doi:10.1111/1756-185X.12380
   PubMed Web of Science ®Google Scholar
• Feijóo M, Túnez I, Tasset I, et al. Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases. Pharmacology. 2009;83(4):211–216. doi:10.1159/000200022
   PubMed Web of Science ®Google Scholar
• Stokes MB, Foster K, Markowitz GS, et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005;20(7):1400–1406. doi:10.1093/ndt/gfh832
   PubMed Web of Science ®Google Scholar
• Ahn JK, Huang B, Bae EK, et al. The role of α-defensin-1 and related signal transduction mechanisms in the production of IL-6, IL-8 and MMPs in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford). 2013;52(8):1368–1376. doi:10.1093/rheumatology/ket147
   PubMed Web of Science ®Google Scholar
• Okcu M, Oktayoglu P, Mete N, et al. A useful marker in the assessment of remission and activation of disease in patients with rheumatoid arthritis: serum human neutrophil peptides 1-3. J Back Musculoskelet Rehabil. 2018;31(6):1145–1150. doi:10.3233/BMR-160743
   PubMed Web of Science ®Google Scholar
• Orozco G, Eyre S, Hinks A, et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2011;70(3):463–468. doi:10.1136/ard.2010.137174
   PubMed Web of Science ®Google Scholar
• Poljak-Blazi M, Hrvacić B, Zupanović Z, Hadzija M, Stanić B, Polancec D. Differing effects of two iron compounds on experimental arthritis, TNF-alpha levels and immune response in mice. Int Immunopharmacol. 2003;3(13–14):1743–1749. doi:10.1016/S1567-5769(03)00204-2
   PubMed Web of Science ®Google Scholar
• Muõz C, Olivares M. Transferrin modulates tumor necrosis factor-alpha secretion by cultured human mononuclear cells: influence of iron status. Nutrition. 2000;16(3):229–230. doi:10.1016/s0899-9007(99)00276-2
   PubMed Web of Science ®Google Scholar
• Gazouli M, Anagnostopoulos AK, Papadopoulou A, et al. Serum protein profile of Crohn’s disease treated with infliximab. J Crohns Colitis. 2013;7(10):e461–70. doi:10.1016/j.crohns.2013.02.021
   PubMedGoogle Scholar
• Shi M, Cui F, Liu AJ, et al. The protective effects of chronic intermittent hypobaric hypoxia pretreatment against collagen-induced arthritis in rats. J Inflamm (Lond). 2015;12:23. doi:10.1186/s12950-015-0068-1
   PubMed Web of Science ®Google Scholar
• Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46(3):742–751. doi:10.1002/eji.201545784
   PubMed Web of Science ®Google Scholar
• Li G, Zhang Y, Qian Y, et al. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway. Mol Immunol. 2013;53(3):227–236. doi:10.1016/j.molimm.2012.08.018
   PubMed Web of Science ®Google Scholar
• Li GQ, Zhang Y, Liu D, et al. PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial-mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis. Mol Cell Biochem. 2013;372(1–2):221–231. doi:10.1007/s11010-012-1463-z
   PubMed Web of Science ®Google Scholar
• Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822. doi:10.1038/s41419-019-2064-5
   PubMed Web of Science ®Google Scholar
• Chen LL, Huang YJ, Cui JT, Song N, Xie J. Iron Dysregulation in Parkinson’s Disease: focused on the Autophagy-Lysosome Pathway. ACS Chem Neurosci. 2019;10(2):863–871. doi:10.1021/acschemneuro.8b00390
   PubMed Web of Science ®Google Scholar